Pathios Therapeutics
Milton, United Kingdom · Founded 2017 · $33.8M raised
- Headquarters
- Milton
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- pathiostherapeutics.com
- Total Funding
- $33.8M
- Last Round
- $25.0M Series BApr 2024
- Rounds
- 3
About
Pathios Therapeutics is a clinical-stage oncology and immunology company targeting GPR65 to restore immune response to cancer.
Summary
Pathios Therapeutics is a Biotech company based in Milton, United Kingdom, founded in 2017. It has raised $33.8M in total across 3 rounds, most recently a $25.0M Series B round in Apr 2024. Investors include Brandon Capital Partners, Canaan Partners and Innovate UK.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pathios-therapeutics"><img src="https://indexed.vc/api/badge/company/pathios-therapeutics" alt="Pathios Therapeutics on Indexed.vc" width="260" height="76" /></a>